{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T16:40:03Z","timestamp":1766940003578},"reference-count":50,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2004,9,7]],"date-time":"2004-09-07T00:00:00Z","timestamp":1094515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Deutsche Derma Gesell"],"published-print":{"date-parts":[[2004,10]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>In den letzten Jahren zeigt sich ein rapider Inzidenz\u2010Anstieg der Syphilis speziell in der Population homosexueller M\u00e4nner. Aufgrund der erh\u00f6hten Suszeptibilit\u00e4t gegen\u00fcber einer HIV\u2010Infektion durch eine Syphilis\u2010Infektion, und dem wechselnden Sexualverhalten mit ansteigender Promiskuit\u00e4t und nachlassendem Kondomgebrauch, ist auch ein erneuter Anstieg der HIV\u2010Inzidenz in dieser Population zu beobachten. Der Verlauf der Syphilis zeigt bei HIV\u2010Koinfektion geh\u00e4uft klinisch atypische und foudroyante Verl\u00e4ufe. Stadienspezifisch finden sich bei der Manifestation der Syphilis bei HIV\u2010Koinfektion im Prim\u00e4rstadium vermehrt multiple Ulzerationen, im Sekund\u00e4rstadium zahlreiche atypische kutane Variationen, sowie geh\u00e4uft eine rasche Progression ins Sekund\u00e4r\u2010 oder Terti\u00e4rstadium. Aufgrund h\u00e4ufiger Serumabnormit\u00e4ten und falsch positiver\/negativer Testergebnisse ist auch die serologische Diagnostik erschwert. Eine erh\u00f6hte Affektion des ZNS durch die HIV\u2010Koinfektion wird aktuell kontrovers diskutiert und konnte in prospektiven Studien bislang nicht eindeutig belegt werden. Eine Liquordiagnostik aller HIV\u2010Koinfizierten mit Sp\u00e4tsyphilis oder unklarem Infektionszeitpunkt wird jedoch bereits heute von der WHO und CDC empfohlen. Die Therapie der Syphilis bei HIV\u2010Koinfektion ist mit Penicillin weltweit weitestgehend einheitlich. So wird die Fr\u00fchsyphilis mit 2,4\u2005Mio.\u2005IE Benzathin\u2010Penicillin ein bzw. zweimalig und die Sp\u00e4tsyphilis mit zwei bzw. dreimaliger Gabe von 2,4\u2005Mio.\u2005IE Benzathin\u2010Penicillin jeweils i.\u2003m. therapiert. Bei klinischen oder serologischen Zeichen einer Neurosyphilis sollte mit 18\u200a\u2013\u200a24\u2005Mio.\u2005IE Penicillin \u00fcber mindestens 14\u2005Tage i.v. therapiert werden.<\/jats:p>","DOI":"10.1046\/j.1439-0353.2004.04071.x","type":"journal-article","created":{"date-parts":[[2004,9,7]],"date-time":"2004-09-07T15:42:27Z","timestamp":1094571747000},"page":"833-840","source":"Crossref","is-referenced-by-count":10,"title":["Syphilis bei HIV\u2010Koinfektion"],"prefix":"10.1111","volume":"2","author":[{"given":"Andreas","family":"K\u00f6rber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Dissemond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Lehnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Franckson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Grabbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Esser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,9,7]]},"reference":[{"key":"e_1_2_11_2_2","unstructured":"RKI. Aktuelle Entwicklung der Syphilis in Deutschland. Epidem Bull 2002; 39: 329\u200a\u2013\u200a336."},{"key":"e_1_2_11_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-003-0606-2"},{"key":"e_1_2_11_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-003-0051-5"},{"key":"e_1_2_11_5_2","unstructured":"RKI. 15. Kongress der International Society for Sexually Transmitted Diseases (ISSTDR) in Ottawa. Epidem Bull 2004; 1: 5\u200a\u2013\u200a6."},{"key":"e_1_2_11_6_2","unstructured":"CDC. Internet use and early syphilis infection among men who have sex with men \u2013 San Francisco California 1999\u200a\u2013\u200a2003. Morb Mortal Wkly Rep 2003; 52: 1229\u200a\u2013\u200a1132."},{"key":"e_1_2_11_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-200005000-00004"},{"key":"e_1_2_11_8_2","doi-asserted-by":"publisher","DOI":"10.1086\/315209"},{"key":"e_1_2_11_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.12.2.187"},{"key":"e_1_2_11_10_2","doi-asserted-by":"crossref","unstructured":"BrockmeyerNH. Syphilis. In: Petzoldt D Gross G Editor. Diagnostik und Therapie sexuell \u00fcbertragbarer Krankheiten \u2013 Leitlinien 2001. Berlin Heidelberg: Springer; 2001: 101\u200a\u2013\u200a112.","DOI":"10.1007\/978-3-642-56883-1_17"},{"key":"e_1_2_11_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007435-200103000-00007"},{"key":"e_1_2_11_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-003-0608-0"},{"key":"e_1_2_11_13_2","doi-asserted-by":"crossref","unstructured":"Braun\u2010FalcoO PlewigG WolffHH. Syphilis. In: Braun\u2010Falco O Plewig G Wolff HH editor. Dermatologie und Venerologie. 4th. ed. Berlin Heidelberg New York: Springer; 1996: 125\u200a\u2013\u200a160.","DOI":"10.1007\/978-3-642-86183-3"},{"key":"e_1_2_11_14_2","first-page":"463","article-title":"Hautmanifestationen der Syphilis maligna bei HIV\u2010Infektion","volume":"7","author":"Schr\u00f6ter R","year":"1988","journal-title":"Hautarzt"},{"key":"e_1_2_11_15_2","doi-asserted-by":"crossref","unstructured":"K\u00f6rberA DissemondJ HillenU EsserS.HIV\u2010positiver Patient mit multiplen Ulcerationen Hautarzt2003;11:1098\u200a\u2013\u200a1002.","DOI":"10.1007\/s00105-003-0619-x"},{"key":"e_1_2_11_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1995.tb04441.x"},{"key":"e_1_2_11_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1439-0353.2002.02106.x"},{"key":"e_1_2_11_18_2","first-page":"393","article-title":"Abnormer Verlauf der Syphilis bei HIV\u2010Infektionen","volume":"5","author":"Mahrle G","year":"1989","journal-title":"Z Hautkr"},{"key":"e_1_2_11_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-199910000-00005"},{"key":"e_1_2_11_20_2","doi-asserted-by":"publisher","DOI":"10.1258\/0956462971919912"},{"key":"e_1_2_11_21_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200262100-00003"},{"key":"e_1_2_11_22_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.105158"},{"key":"e_1_2_11_23_2","first-page":"171","article-title":"Neuroretinitis due to seronegative syphilis associated with human immunodeficiency virus","volume":"3","author":"Halperin LS","year":"1992","journal-title":"J Clin Neuroophthalmol"},{"key":"e_1_2_11_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(90)32605-2"},{"key":"e_1_2_11_25_2","unstructured":"RKI. Syphilis Ratgeber f\u00fcr \u00c4rzte. Epidem Bull 2003; 30: 229\u200a\u2013\u200a234."},{"key":"e_1_2_11_26_2","doi-asserted-by":"publisher","DOI":"10.1067\/S0190-9622(03)00484-5"},{"key":"e_1_2_11_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.1999.tb01791.x"},{"key":"e_1_2_11_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(89)80316-0"},{"key":"e_1_2_11_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-198808000-00012"},{"key":"e_1_2_11_30_2","first-page":"374","article-title":"Gummatous lesions in men infected with human immunodeficiency virus and syphilis","volume":"66","author":"Hay PE","year":"1990","journal-title":"Genitourin Med"},{"key":"e_1_2_11_31_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.7.1282"},{"key":"e_1_2_11_32_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-109-11-855"},{"key":"e_1_2_11_33_2","doi-asserted-by":"publisher","DOI":"10.1086\/318722"},{"key":"e_1_2_11_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198706183162503"},{"key":"e_1_2_11_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199707313370504"},{"key":"e_1_2_11_36_2","doi-asserted-by":"publisher","DOI":"10.1086\/381227"},{"key":"e_1_2_11_37_2","unstructured":"DGN. Neurosyphilis\u2010Leitlinien der deutschen Gesellschaft f\u00fcr Neurologie 2002."},{"key":"e_1_2_11_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-003-0634-y"},{"key":"e_1_2_11_39_2","unstructured":"HagedornH. Syphilis. Qualit\u00e4tsstandards in der mikrobiologisch\u2010infektiologischen Diagnostik. Urban und Fischer 2001: 1\u200a\u2013\u200a40."},{"key":"e_1_2_11_40_2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0733-8635(18)30397-8","article-title":"Syphilis and HIV infection","volume":"3","author":"Hicks CB","year":"1991","journal-title":"Dermatol Clin"},{"key":"e_1_2_11_41_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1063704"},{"key":"e_1_2_11_42_2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/095646249300400208","article-title":"Determining the prevalence of neurosyphilis in a cohort coinfected with HIV","volume":"2","author":"Branden WR","year":"1993","journal-title":"Int J STD AIDS"},{"key":"e_1_2_11_43_2","doi-asserted-by":"publisher","DOI":"10.1086\/517330"},{"key":"e_1_2_11_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00105-003-0611-5"},{"key":"e_1_2_11_45_2","unstructured":"RKI. Praktische Empfehlung zur Serodiagnostik der Syphilis (Ergebnisse einer Konsensusempfehlung des RKI und der DSTDG). Epidem Bull 2003; 25: 191\u200a\u2013\u200a192."},{"key":"e_1_2_11_46_2","unstructured":"CDC. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002; 10: 1\u200a\u2013\u200a78."},{"key":"e_1_2_11_47_2","unstructured":"GohBT Van VoorstVader PC. European Branch of the International Union against Sexually Transmitted Infection and the European Office of the World Health Organization. European guideline for the management of syphilis. Int J STD AIDS2001; Suppl 3:14\u200a\u2013\u200a26."},{"key":"e_1_2_11_48_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.11.1510"},{"key":"e_1_2_11_49_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198706183162507"},{"key":"e_1_2_11_50_2","doi-asserted-by":"publisher","DOI":"10.4065\/74.1.53"},{"key":"e_1_2_11_51_2","doi-asserted-by":"crossref","unstructured":"Malone JL Wallace MR Hendrick BB LaRocco A Jr Tonon E Brodine SK Bowler WA Lavin BS Hawkins RE Oldfield EC 3rd. Syphilis and neurosyphilis in a human immunodeficiency virus type\u20101 seropositive population: evidence for frequent serologic relapse after therapy. Am J Med.1995; 1: 55\u200a\u2013\u200a63.","DOI":"10.1016\/S0002-9343(99)80105-3"}],"container-title":["JDDG: Journal der Deutschen Dermatologischen Gesellschaft"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1439-0353.2004.04071.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1439-0353.2004.04071.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T08:59:44Z","timestamp":1697187584000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1439-0353.2004.04071.x"}},"subtitle":["Syphilis with HIV coinfection"],"short-title":[],"issued":{"date-parts":[[2004,9,7]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["10.1046\/j.1439-0353.2004.04071.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1439-0353.2004.04071.x","archive":["Portico"],"relation":{},"ISSN":["1610-0379","1610-0387"],"issn-type":[{"value":"1610-0379","type":"print"},{"value":"1610-0387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,7]]}}}